Prevention of plaque rupture: A new paradigm of therapy

被引:38
作者
Forrester, JS [1 ]
机构
[1] Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA
关键词
D O I
10.7326/0003-4819-137-10-200211190-00012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute coronary syndromes-unstable angina, myocardial infarction, and sudden cardiac death-are caused by acute disruption of an unstable coronary atheroma. Unstable plaques have three histologic characteristics: a large lipid core, many inflammatory cells, and a thin fibrous cap. Because the unstable plaque is not necessarily obstructive, it may cause no symptoms before rupture. The cellular processes that lead to the characteristic histologic features of unstable plaque have recently been identified. This new understanding of the cell biology of plaque instability suggests new therapeutic strategies: passivation of the endothelium, reduction of low-density lipoprotein (LDL) in the vessel wall by decreasing serum LDL levels or accelerating reverse cholesterol transport, inhibition of LDL oxidation, inhibition of inflammatory cytokine expression, and inhibition of thrombus formation. Although the morbidity and mortality resulting from acute coronary disease have been reduced by more than :50% over the past 30 years, it is reasonable to anticipate further reductions of similar magnitude in the decade ahead.
引用
收藏
页码:823 / 833
页数:11
相关论文
共 103 条
[91]  
VANDERWAL AC, 1992, AM J PATHOL, V141, P1427
[92]  
VERLANGIERI AJ, 1992, J AM COLL NUTR, V11, P131
[93]   Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis:: a randomised, placebo-controlled trial [J].
Vermeulen, EGJ ;
Stehouwer, CDA ;
Twisk, JWR ;
van den Berg, M ;
de Jong, SC ;
Mackaay, AJC ;
van Campen, CMC ;
Visser, FC ;
Jakobs, CAJM ;
Bulterijs, EJ ;
Rauwerda, JA .
LANCET, 2000, 355 (9203) :517-522
[94]  
VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131
[95]   Cholesterol lowering and endothelial function [J].
Vogel, RA .
AMERICAN JOURNAL OF MEDICINE, 1999, 107 (05) :479-487
[96]  
Vollset SE, 2001, AM J CLIN NUTR, V74, P130
[97]   Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque [J].
Wallner, K ;
Li, C ;
Shah, PK ;
Fishbein, MC ;
Forrester, JS ;
Kaul, S ;
Sharifi, BG .
CIRCULATION, 1999, 99 (10) :1284-1289
[98]   Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis -: Evidence for involvement of the renin-angiotensin system [J].
Warnholtz, A ;
Nickenig, G ;
Schulz, E ;
Macharzina, R ;
Bräsen, JH ;
Skatchkov, M ;
Heitzer, T ;
Stasch, JP ;
Griendling, KK ;
Harrison, DG ;
Böhm, M ;
Meinertz, T ;
Münzel, T .
CIRCULATION, 1999, 99 (15) :2027-2033
[99]  
Woollett LA, 1997, J LIPID RES, V38, P2289
[100]   Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages [J].
Xu, XP ;
Meisel, SR ;
Ong, JM ;
Kaul, S ;
Cercek, B ;
Rajavashisth, TB ;
Sharifi, B ;
Shah, PK .
CIRCULATION, 1999, 99 (08) :993-998